Press Releases

CIT strengthens services in immunotoxicology

CIT, a leading European CRO specializing in non-clinical health and safety research, is pleased to announce the appointment of a new multi-disciplinary team of experienced scientists dedicated to providing non-clinical, advanced immunological research. The team, comprising of study directors,...

PharmaDiagnostics’ SoPRano (TM) wins prestigious product award at SBS 2011

PharmaDiagnostics NV, a company developing and marketing a broadly-enabling, label-free screening technology that uniquely does not require specialized equipment, announces today that their SoPRano(TM) technology has won its third award in 12 months. SoPRano was awarded an SLAS (Society...

Sun Pharma and Merck Establish Joint Venture to Develop and Commercialize Novel Formulations and Combinations of Medicines

Merck & Co., Inc., a global health care leader, known as MSD outside the United States and Canada,and Sun Pharmaceutical Industries Ltd., (“Sun Pharma”) a leading Indian multinational pharmaceutical company, today announced the creation of a joint venture...

Integromics and Ingenuity expand their co-operation with the integration of a fourth Integromics product to Ingenuity’s IPA

Integromics, a market leader in IT solutions for life sciences in the field of genomics and proteomics, today announces that it has extended its partnership with Ingenuity(R), a provider of information and analytics solutions for life science researchers. The...

AstraZeneca demonstrates commitment to predictive science at international modelling conference

The 2011 American Conference of Pharmacometrics (ACOP) got underway this weekend with attendees from around the world converging on San Diego, US - including a delegation and dedicated exhibition team from AstraZeneca. Now in...

Oncodesign offers world’s most comprehensive collection of patient-derived colorectal tumor models

Oncodesign announced today that the company has acquired exclusive commercialization rights to distribute the world’s most comprehensive collection of human colorectal cancer models directly developed from patient’s tumors. Oncodesign’s clients can now access the entire collection to evaluate therapeutic...

CIT launches LeadScreen (TM), a new range of fast, cost-effective services for drug candidate selection

CIT, a leading European non-clinical CRO specialized in health and safety research, announces today a new range of fast and economical services to meet the growing needs of companies developing the drugs of tomorrow. The services, grouped under the...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read